297 related articles for article (PubMed ID: 38726411)
1. Oridonin from
Ali MA; Khan N; Ali A; Akram H; Zafar N; Imran K; Khan T; Khan K; Armaghan M; Palma-Morales M; Rodríguez-Pérez C; Caunii A; Butnariu M; Habtemariam S; Sharifi-Rad J
Food Sci Nutr; 2024 May; 12(5):3046-3067. PubMed ID: 38726411
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in oridonin derivatives with anticancer activity.
Sobral PJM; Vicente ATS; Salvador JAR
Front Chem; 2023; 11():1066280. PubMed ID: 36846854
[TBL] [Abstract][Full Text] [Related]
3. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
4. Solubility and Bioavailability Enhancement of Oridonin: A Review.
Zhang Y; Wang S; Dai M; Nai J; Zhu L; Sheng H
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947574
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and Evaluation of Liposomes Containing Oridonin from
Wang Y; Wang M; Lin F; Zhang X; Zhao Y; Guo C; Wang J
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164121
[TBL] [Abstract][Full Text] [Related]
7. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ
Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma.
Cao S; Huang Y; Zhang Q; Lu F; Donkor PO; Zhu Y; Qiu F; Kang N
Apoptosis; 2019 Feb; 24(1-2):33-45. PubMed ID: 30430397
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.
Xu ZZ; Fu WB; Jin Z; Guo P; Wang WF; Li JM
Leuk Lymphoma; 2016; 57(4):888-98. PubMed ID: 26415087
[TBL] [Abstract][Full Text] [Related]
10. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines.
Bai N; He K; Zhou Z; Tsai ML; Zhang L; Quan Z; Shao X; Pan MH; Ho CT
Planta Med; 2010 Feb; 76(2):140-5. PubMed ID: 19653147
[TBL] [Abstract][Full Text] [Related]
11. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
[TBL] [Abstract][Full Text] [Related]
12. Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells.
Zhang J; Wang N; Zhou Y; Wang K; Sun Y; Yan H; Han W; Wang X; Wei B; Ke Y; Xu X
Phytother Res; 2021 Jan; 35(1):494-503. PubMed ID: 32869425
[TBL] [Abstract][Full Text] [Related]
13. Molecular Insight in the Multifunctional Effects of Oridonin.
Owona BA; Schluesener HJ
Drugs R D; 2015 Sep; 15(3):233-44. PubMed ID: 26290464
[TBL] [Abstract][Full Text] [Related]
14. [Determination of oridonin and rosemarinic acid in Rabdosia rubescens by HPLC].
Wang K; Zhang ZQ
Zhong Yao Cai; 2007 Nov; 30(11):1396-8. PubMed ID: 18323207
[TBL] [Abstract][Full Text] [Related]
15. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.
He H; Jiang H; Chen Y; Ye J; Wang A; Wang C; Liu Q; Liang G; Deng X; Jiang W; Zhou R
Nat Commun; 2018 Jun; 9(1):2550. PubMed ID: 29959312
[TBL] [Abstract][Full Text] [Related]
16. Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies.
Zhao Z; Chen Y
Curr Pharm Biotechnol; 2014; 15(11):1083-92. PubMed ID: 25391243
[TBL] [Abstract][Full Text] [Related]
17. Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells.
Yang H; Gao Y; Fan X; Liu X; Peng L; Ci X
Front Oncol; 2019; 9():769. PubMed ID: 31475112
[TBL] [Abstract][Full Text] [Related]
18. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway.
Cao S; Xia M; Mao Y; Zhang Q; Donkor PO; Qiu F; Kang N
Int J Oncol; 2016 Nov; 49(5):2075-2087. PubMed ID: 27667173
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells.
Gao F; Tang Q; Yang P; Fang Y; Li W; Wu Y
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e114-22. PubMed ID: 19302235
[TBL] [Abstract][Full Text] [Related]
20. Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells.
Dal Piaz F; Cotugno R; Lepore L; Vassallo A; Malafronte N; Lauro G; Bifulco G; Belisario MA; De Tommasi N
J Proteomics; 2013 Apr; 82():14-26. PubMed ID: 23416714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
